Abstract
The use of totally implantable venous access devices (VADs) has favorably changed the clinical management and, consequently, the quality of life (QoL) of patients requiring long-term intravenous therapy, including cancer patients. Despite their many advantages, venous access devices sometimes present functional and emotional problems. So advantages and disadvantages of the VAD from the patient’s perspective should also be an important part in the selection of the type of device. The more frequent complications that arise with the use of port and tunneled catheters are physical, such as infections, thrombosis, obstructions, sleeve formation, and extravasation. But, in addition to medical issues, patients also experience psychosocial problems that can interfere with their QoL. So the patient’s subjective experience of living with an implanted VAD has to be carefully considered, even if few publications discuss the psychological experience of the patient and the impact of the VADs on his or her QoL. Sometimes also excellent papers, updating the use of totally implantable venous access devices, do not discuss patient’s emotional problems [30].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Barsevick A, Frost M, Zwinderman A et al (2010) On behalf of the geneqol Consortium. I’m so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res 19:1419–1427
Biffi R, Orsi F, Pozzi S et al (2011) No impact of central venous insertion site on oncology patients’ quality of life and psychological distress. A randomized three-arm trial. Support Care Cancer 19:1573–1580
Bow EJ, Kilpatrick MG, Clinch JJ (1999) Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: a randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 17:1267–1273
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9
Carver CS (1997) You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med 4(1):92–100
Chaturvedi S, Ieraci V, Torta R (2014) Treatment of somatoform disorders and other somatic symptom condition (pain, fatigue, hot flashes, pruritus). In: Grassi L, Riba M (eds) Psychopharmacology in oncology and palliative care – a practical manual. Springer, Germany
Chernecky C (2002) Satisfaction versus dissatisfaction with venous access devices in outpatient oncology: a pilot study. Oncol Nurs Forum 29(7):1029–1030
Cloninger CR, Przybeck TR, Svrakic DM (1991) The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep 69:1047–1057
Dearborn P, De Muth JS, Requarth AB et al (1997) Nurse and patient satisfaction with three types of venous access devices. Oncol Nurs Forum 24(1 Suppl):34–40
Goossens GA, Vrebos M, Stas M et al (2005) Central vascular access devices in oncology and hematology considered from a different point of view. J Infus Nurs 28:61–67
Grassi L, Johansen C, Torta R et al, on behalf of the Italian Society of Psycho-Oncology Distress Thermometer Study Group (2013) Screening for distress in cancer patients. A multicenter, nationwide study in Italy. Cancer 119 (9):1714–1721
Grassi L, Torta R, Varetto A et al (2005) Styles of coping with cancer: the Italian version of the Mini-Mental Adjustment to Cancer (Mini-MAC) scale. Psychooncology 14(2):115–124
Howell D, Keller-Olaman S, Oliver TK et al (2013) A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol 20(3):e233–e246
Huisman-de Waal G, Schoonhoven L, Jansen J et al (2007) The impact of home parenteral nutrition on daily life-a review. Clin Nutr 26:275–288
Huisman-de Waal G, Versleijen M, van Achterberg T et al (2011) Psychosocial complaints are associated with venous access-device related complications in patients on home parenteral nutrition. JPEN J Parenter Enteral Nutr 35(5):588–595
Johansson E, Engervall P, Björvell H et al (2009) Patients’ perceptions of having a central venous catheter or a totally implantable subcutaneous port system – results from a randomised study in acute leukaemia. Support Care Cancer 17:137–143
Kearns NP, Cruickshank CA, McGuigan KJ et al (1982) A comparison of depression rating scales. Br J Psychiatry 141:45–49
Lilienberg A, Bengtsson M, Starkhammar H (1994) Implantable devices for venous access: nurses’ and patients’ evaluation of three different port systems. J Adv Nurs 19(1):21–28
Mitchell SA, Beck SL, Hood LE et al (2007) Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 11:99–113
National Cancer Institute (NCI) (2013) United States, National Institutes of Health, Fatigue (PDQ). Health Professional Information [Web page]. NCI, Bethesda
National Comprehensive Cancer Network (2009) NCCN clinical practice guidelines in oncology: cancer-related fatigue. Ver. 2.2009. NCCN, Fort Washington
Rodgers HC, Liddle K, Nixon SJ et al (1998) Totally implantable venous access devices in cystic fibrosis: complications and patients’ opinions. Eur Respir J 12(1):217–220
Torta RG, Ieraci V (2013) Depressive disorders and pain: a joint model of diagnosis and treatment. J Pain Relief S2. http://dx.doi.org/10.4172/2167-0846.S2-003
Torta R, Varetto A, Binaschi L (2006) Emotional problems in patients with totally implantable venous access system (PORT). Psychooncology 15(S2):445
Torta R, Varetto A, Sandrucci S et al (2000) Totally implantable venous systems (port) and quality of life. Ann Oncol 11(2):29
Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
World Health Organization (2008) Millennium Development Goal 5 – improving maternal health. WHO
Xiao C (2010) The state of science in the study of cancer symptom clusters. Eur J Oncol Nurs 14:417–434
Zaghal A, Khalife M, Mukherji D et al (2012) Update on totally implantable venous access devices. Surg Oncol 21:207–215
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Torta, R., Ieraci, V. (2014). Venous Access Devices and Emotional Response in Oncologic Patients: Diagnostic and Management Aspects. In: Sandrucci, S., Mussa, B. (eds) Peripherally Inserted Central Venous Catheters. Springer, Milano. https://doi.org/10.1007/978-88-470-5665-7_13
Download citation
DOI: https://doi.org/10.1007/978-88-470-5665-7_13
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5664-0
Online ISBN: 978-88-470-5665-7
eBook Packages: MedicineMedicine (R0)